Citizens Financial Group Inc Exelixis, Inc. Transaction History

Citizens Financial Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$20.67 - $26.94 $4,960 - $6,465	-240 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$16.46 - $27.42 $4,625 - $7,705	-281 Reduced 53.93%	240 $6,000
Q1 2020 May 08, 2020	BUY	$14.46 - $21.8 $5,697 - $8,589	394 Added 310.24%	521 $9,000
Q4 2019 Feb 07, 2020	BUY	$15.15 - $18.89 $1,924 - $2,399	127 New	127 $2,000

504

243M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.1B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Citizens Financial Group Inc with notifications on news.